Over-the-counter painkillers: the risks of ibuprofen, naproxen and other NSAIDs

Updated Six Habits Editorial Team
The short answerNonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, naproxen and diclofenac, are sold over the counter but are not risk-free. An analysis of data from more than 440,000 people found that all NSAIDs studied were linked to higher risk of heart attack within the first week of use, especially at high doses. They can also harm the stomach and kidneys.

Key points

What the research shows

A Bayesian meta-analysis of health records from more than 446,000 people in Canada and Europe found that all NSAIDs studied, including ibuprofen, naproxen, diclofenac and celecoxib, were linked to a higher risk of heart attack, roughly 20% to 75% higher depending on the drug. Risk appeared within the first week of use and was highest in the first month and at higher doses (Bally et al., 2017). The FDA strengthened its warning about heart attack and stroke risk from NSAIDs in 2015.

Other risks

Back and joint pain

For low back pain, guidelines emphasize staying active and exercise over long-term medication (Foster et al., 2018).

How to take them more safely

Frequently asked questions

Is acetaminophen (Tylenol) safer?

It does not carry the same heart and stomach risks, but too much can cause serious liver damage. Do not exceed the label dose, and check combination products for hidden acetaminophen.

Does low-dose aspirin count?

Aspirin is also an NSAID but is used differently. Taking ibuprofen can interfere with aspirin’s heart-protective effect; ask your doctor about timing.

Sources

  1. Bally et al. (2017). Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data. BMJ :j1909. doi:10.1136/bmj.j1909
  2. Foster et al. (2018). Prevention and treatment of low back pain: evidence, challenges, and promising directions. The Lancet 391(10137):2368-2383. doi:10.1016/S0140-6736(18)30489-6
  3. Glass et al. (2005). Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 331(7526):1169. doi:10.1136/bmj.38623.768588.47

Prepared according to our evidence methodology and the principles of lifestyle medicine. For education only; it does not replace advice from your doctor.

Keep reading

Related topics from other pillars

Risky Substances tools